Funding for Faculty

Additional Details

RFP Snapshot: The Siteman Cancer Center (SCC) Biostatistics and Qualitative Research Shared Resource (BQSR) fulfills a critical function by providing methodologic and analytic support for the development and conduct of scientifically sound, innovative cancer research at SCC. Advances in biotechnologies and computing systems/software increasingly require specialized expertise and tools for sophisticated statistical methodologies. Qualitative research requires sound methods and approaches that support rigor and best practice. The overarching goal of the BQSR is to provide a comprehensive, centralized, and accessible biostatistics and qualitative support infrastructure for all phases of cancer research; from study development and design to data collection, ongoing monitoring, and final analysis.

Max Amount and Period: N/A

Eligibility: Must be a Siteman Cancer Center member.

Due Date: Rolling

Additional Details

RFP Snapshot: The WUSTL Center for Drug Discovery offer the CDD Match Grant15 and Grant25 programs.

Match Grant15 is to advance translational small-molecule drug discovery research at Washington University. CDD offers a full suite of preclinical drug discovery services and know-how. Capabilities range from drug lead finding utilizing the High Throughput Screening Core to Medicinal Chemistry-driven drug lead optimization, ADME profiling, and in vivopharmacokinetics for proof-of-concept in vivo pharmacology studies, intellectual property (patent) filing, and drug development.

Match Grant25 is a follow-on award program meant only for those investigators who have successfully completed and met the objectives of a Match Grant15 (or the original CDD MicroGrant) award and request additional match funds to further advance the discovery research project. CDD offers a full suite of preclinical drug discovery services and know-how. Capabilities range from drug lead finding utilizing the High Throughput Screening Core to Medicinal Chemistry-driven drug lead optimization, ADME profiling, and in vivo pharmacokinetics for proof-of-concept in vivo pharmacology studies, intellectual property (patent) filing, and drug development.

Max Amount and Period:

Match Grant15 – $7,500 from CDD

Match Grant25 – $12,000 from CDD

Eligibility:

Match Grant15 – open to investigators with a faculty appointment at Washington University

Match Grant25 – open only to WashU faculty who have successfully completed a Match Grant15 (or CDD MicroGrant) and submitted a final research report.

Due Date: Rolling

Additional Details

RFP Snapshot: The purpose of the awards is to advance initial discovery pilots for Precision Health ICTS investigators. Proposals are not for developed projects but are to fund developmental or early stage work, including pilot data collection and analysis, in preparation for submission of future external funding.

Max Amount and Period: $25,000 for 1 year

Eligibility: Applicants must be full time faculty (instructor level or above) at Washington University in St. Louis or an ICTS partner institution. Applicant must be a member of the ICTS.

Due Date: Rolling

Additional Details

RFP Snapshot: The Just-In-Time (JIT) Core Usage Funding Program is designed to provide quick access to funding to use any of the JIT Cores (pdf) for research advancing medical knowledge that can improve human health. Siteman Cancer Center will co-sponsor cancer-focused proposals.

Max Amount and Period: Varies

Eligibility: Applicant must be a registered member of the ICTS and hold a faculty level appointment at WUSTL or an ICTS partner institution.

Due Date: Rolling

Additional Details

RFP Snapshot: The intent of the EDS Accelerator Award is to support the commercialization of an ongoing cancer research project and to validate and de-risk technologies. Proposals should address key experiments required to move findings toward commercialization, that do not easily fit into traditional funding mechanisms. This mechanism is not designed to initiate new projects or develop new directions for an ongoing project. The proposal should be commercially driven with the PI having a plan to license the technology, either to an established company or a start-up if the experiment(s) are successful.

Max Amount and Period: $75,000 for 1 year

Eligibility: Applicants must be current or former ACS grantees (including IRG pilot grant awardees) or former ACS postdoctoral fellows. Applicants must have a full-time faculty appointment and may be at any career stage. Applicant should be motivated to commercialize their technology.

Due Date: Rolling

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: We are seeking novel cancer agents approaching preclinical and/or clinical development with supporting in vivo efficacy data. We will consider all technology areas, including small molecule, biological and other therapeutics.

Max Amount and Period: This opportunity provides resources for clinical development of new cancer treatments.

Eligibility: Just need to be based at an academic insitution or pharmaceutical or biotech company in the UK or international.

Due Date: Rolling

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: Young Investigator Accelerator Awards aim to attract early career faculty with original ideas into the field of colorectal cancer research, thereby recruiting and supporting the next generation of CRC research leaders. Awardees will be provided funding to accomplish innovative and original, preclinical, translational, and/or early clinical research projects.

Max Amount and Period: $200,000 over 2 years

Eligibility: Applicants must be within the first five years of their first independent, full-time academic or nonprofit faculty appointment.

Due Date: Rolling

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The Team Science Accelerator Award will support team science, including public-private partnerships, that will accelerate CRC research to curative science. Research proposals will be considered that accelerate new therapeutic and technology innovations from bench to bedside and address unmet clinical needs.

Max Amount and Period: $500,000 over 2 years

Eligibility: Principal Investigator of a Team Accelerator Award proposal must be a senior investigator with more than five years of active research in colorectal cancer. Research teams may be from a single institution or multiple institutions. Research teams may include both academic, non-profit and industry (biotech/pharma) researchers.

Due Date: Rolling

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: Senior Investigator Accelerator Awards will fund potentially transformative ideas that will accelerate the translation of new therapies and technologies to the bedside by the end of the proposed research. Collaborations are highly encouraged.

Max Amount and Period: $500,000 over 2 years

Eligibility: Principal Investigator must be a senior researcher, past the initial five years of their first academic or non-profit faculty appointment. Key collaborators are not required to qualify as a senior researcher.

Due Date: Rolling

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: Pioneering Ideas: Exploring the Future to Build a Culture of Health welcomes proposals that are primed to influence health equity in the future. We seek ideas that address any of RWJF’s Pioneering Ideas for an Equitable Future team’s four current areas of focus described below: 1) Future of Evidence; 2) Future of Social Interaction; 3) Future of Food; and 4) Future of Work. Additionally, under Open Exploration, also described below, this call for proposals seeks ideas that might fall outside of these four focus areas but which offer unique approaches to advancing health equity and our progress toward a Culture of Health.

Max Amount and Period: No limit for 3 years, but budget must be reasonably supported by scope of project.

Eligibility: Applicant organizations must be based in the US or its territories. Preference will be given to applicant organizations that are either institutes of higher education, public entities, or nonprofits that are tax exempt under Section 501(c)(3) of the Internal Revenue Code.

Due Date: Rolling

Additional Details

RFP Snapshot: The primary objective of proposed Phase I/II or Phase II clinical trials in relapsed/refractory OS should be to improve event free survival (EFS) beyond known historical rates. The proposed trial may be carried out in a single institution, a clinical trial consortium, or through an existing clinical trial infrastructure.

Max Amount and Period: $800,000 over 2-3 years

Eligibility: Applicants must have an MD, PhD, MD/PhD, or equivalent and be appointed as faculty (or equivalent) at an academic institution. Applicants must have a track record of publication and funding productivity that demonstrates the project can be accomplished by the investigators. Research projects may be an extension of ongoing research but cannot overlap with any funded studies unless the applicant clearly demonstrates that new funding will not duplicate existing support.

Due Date: Letter of Intent Due: September 10, 2026 by 11am CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: Correlative studies should seek to generate data from clinical trials aimed at improving EFS of recurrent and metastatic OS patients. Our highest priorities for correlative science proposals are 1) to create the opportunity, should the associated clinical trial fail, to understand the reasons for that failure and allow for productive iteration of the approach; and 2) to identify specific predictors of response.

Max Amount and Period: $200,000 to $500,000 over 2 years

Eligibility: AApplicants must have an MD, PhD, MD/PhD, or equivalent and be appointed as faculty (or equivalent) at an academic institution. • Applicants must have a track record of publication and funding productivity that demonstrates the project can be accomplished by the investigators. • Research projects may be an extension of ongoing research but cannot overlap with any funded studies unless the applicant clearly demonstrates that new funding will not duplicate existing support.

Due Date: Letter of Intent Due: September 10, 2026 by 11am CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: A translational imperative for OSI is to cultivate and support a research agenda that will identify biological dependencies in the disease that can be targeted in patients with a focus on the above-described therapeutic area priorities. Proposals that include some or all the following features will be prioritized: the use of novel laboratory approaches and bioinformatic tools applied to OS cells and a diversity of in vivo models across species and human patient samples. We value both projects designed to enable new clinical studies and foundational research studies that will identify the desired biological dependencies/targets.

Max Amount and Period: $500,000 over 2 years

Eligibility: AApplicants must have an MD, PhD, MD/PhD, or equivalent and be appointed as faculty (or equivalent) at an academic institution. • Applicants must have a track record of publication and funding productivity that demonstrates the project can be accomplished by the investigators. • Research projects may be an extension of ongoing research but cannot overlap with any funded studies unless the applicant clearly demonstrates that new funding will not duplicate existing support.

Due Date: Letter of Intent Due: September 10, 2026 by 11am CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The aim of this grant program is to place less emphasis on preliminary data to encourage projects exploring bold innovations that may fall within any stage of the drug development path, and that seek to deliver curative outcomes to patients with OS. Proposals of high value will be based on innovation and sound scientific hypothesis, and the likelihood that the approach will expand our understanding of OS biology, rather than a narrower focus on testing the potential therapeutic activity of a novel therapeutic approach.

Max Amount and Period: $25,000 to $125,000 for 1 year

Eligibility: Applicants must have an MD, PhD, MD/PhD, or equivalent and be appointed as faculty (or equivalent) at an academic institution. Applicants must have a track record of publication and funding productivity that demonstrates the project can be accomplished by the investigators. Research projects may be an extension of ongoing research but cannot overlap with any funded studies unless the applicant clearly demonstrates that new funding will not duplicate existing support.

Due Date: Letter of Intent Due: September 10, 2026 by 11am CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The AACR-Lobular Breast Cancer Alliance Invasive Lobular Carcinoma Research Challenge Grants is a joint effort to stimulate and develop creative, paradigm-shifting ideas in invasive lobular carcinoma (ILC) that have the potential to advance knowledge of lobular breast cancer detection, diagnosis, pathology, treatment, recurrence prevention, or surveillance.

Max Amount and Period: $50,000 for 1 year

Eligibility: Applicant must:

• Have a doctoral degree (PhD, MD, MD/PhD, or equivalent) in a related field.
• Be independent investigators.
• If eligibility is based on a future position, the position must be confirmed at the time of submission and CANNOT be contingent upon receiving this grant. Applicants are advised to contact the AACR’s Research and Grants Administration (RGA) at [email protected] before submission to confirm they will hold an eligible position.
• Work at an academic, medical, or research institution anywhere in the world
• At the start of the grant term (January 1, 2027), applicants cannot: a) be a candidate for a further doctoral degree, b) be an employee or subcontractor of a U.S. federal government entity or for-profit private industry. They may serve as collaborators, but no grant funds may be directed toward these individuals, c) concurrently hold another AACR grant.

Due Date: September 10, 2026 by Noon CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The purpose of this Request for Proposals (RFP) is to fund research that advances understanding of how insurance status, type, design, and policy changes create barriers to equitable access to cancer care, and that identifies actionable solutions to address these barriers through policy reform and changes in healthcare practice and program delivery.

Max Amount and Period: $750,000 over 3 years

Eligibility: Blood Cancer United welcomes Principal Investigators at all stages of their careers as well as Principal Investigators who have not previously conducted research in the area of blood cancer. However, if the Primary Principal Investigator is an early investigator, a more experienced Co-Principal Investigator is required. The Primary Principal Investigator must have a PhD, MD,
ScD, JD, or equivalent doctoral degree. Co-Principal Investigator(s) may hold other advanced degrees appropriate to their role on the study (e.g., MPP, MPH). The study team must include an individual with expertise in the public policy area(s) most relevant to the proposal (e.g., Medicare, Medicaid, ACA Marketplace plans, commercial insurance).

Due Date: Letter of Intent Due: September 10, 2026 by 2pm CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The Conquer Cancer Young Investigator Award (YIA) provides funding to promising investigators to encourage and promote quality research in clinical oncology. The purpose of this award is to fund physicians during the transition from a fellowship or training program to a faculty appointment. This is a mentored award and the research project is conducted under the guidance of an experienced mentor in the proposed research area. Applications in all areas of cancer research are accepted from U.S. and international applicants.

Max Amount and Period: $50,000 for 1 year

Eligibility: Applicant must have a doctoral degree (including MD, PhD, MD/PhD, DO, or equivalent doctoral degrees). They must be in the last year of a fellowship or training program, or in the first two years of a faculty/staff appointment (if in an academic institution) or first two years of employment (if in a non-academic institution) at the time of grant submission. Must be within 10 years of terminal degree (MD, PhD or equivalent) at the time of application submission. Must be an ASCO member or have submitted a membership application with the grant application. Be able to commit at least 60% of full- time effort in research.

Due Date: Letter of Intent Due: September 10, 2026 by 10:59pm CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The Conquer Cancer Global Oncology Young Investigator Award (GO YIA) provides research funding to early-career investigators to encourage and promote quality research in global oncology and to develop the next generation researchers to address global health needs. This is a mentored award and the research project is conducted under the guidance of an experienced mentor in the proposed research area.

Max Amount and Period: $50,000 for 1 year

Eligibility: Applicant must have a doctoral degree (including MD, PhD, MD/PhD, DO, or equivalent doctoral degrees). They must be in the last year of a fellowship or training program, or in the first two years of a faculty/staff appointment (if in an academic institution) or first two years of employment (if in a non-academic institution) at the time of grant submission. Applicants from low- and middle-income countries (LMICs) are highly encouraged to apply. Must be within 10 years of terminal degree (MD, PhD or equivalent) at the time of application submission. Must be an ASCO member or have submitted a membership application with the grant application. Be able to commit at least 60% of full- time effort in research.

Due Date: Letter of Intent Due: September 10, 2026 by 10:59pm CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The purpose of the Hyundai Bridge2K Award is to provide seed funding to support the resubmission efforts of strong pediatric cancer-focused grant applications that narrowly missed the pay line at national funding agencies. Ideal candidates are those with NIH K award applications (e.g., K08, K23) that were scored.

Max Amount and Period: $150,000 for 1 year

Eligibility: Applicants must either hold an MD or MD/PhD degree, be a pediatric oncologist with a junior faculty position no higher than Assistant Professor, and must have submitted a pediatric cancer-related K award application (K08, K23, K99/R00) within the past 18 months that was scored but not funded (the 18 months begins at review date).

Due Date: Letter of Intent Due: September 12, 2026 by 7pm CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The application must address at least one of the following priority areas related to cancer in children, adolescents and/or young adults up to age 24: • Innovative approaches to research that could lead to advanced studies, better delivery of treatment or clinical translation. • Basic science studies that are likely to lead to a new discovery. • Under-studied cancer types. • Quality of life, survivorship and palliative care studies. • Personalized, targeted, alternative or integrative research proposals. • Data utilization through data standardization, collection, storage, analysis and sharing.

Max Amount and Period: $100,000 over 2 years

Eligibility: Applicants with all academic ranks, Instructor to Professor, and research scientists holding at least an M.D., D.O., Pharm.D. and/or Ph.D. degree may apply. Applicants may be “young investigators” (no more than 5 years post fellowship) or “independent investigators” (more than five years post fellowship).

Due Date: Letter of Intent Due: September 14, 2026 by 2:30pm CST

Application Assistance: Washington University faculty may reach out to Batool Akhtar-Zaidi in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The application must address at least one of the following priority areas related to cancer in children, adolescents and/or young adults up to age 24: • Innovative approaches to research that could lead to advanced studies, better delivery of treatment or clinical translation. • Basic science studies that are likely to lead to a new discovery. • Under-studied cancer types. • Quality of life, survivorship and palliative care studies. • Personalized, targeted, alternative or integrative research proposals. • Data utilization through data standardization, collection, storage, analysis and sharing.

Max Amount and Period: $200,000 over 2 years

Eligibility: Applicants with all academic ranks, Instructor to Professor, and research scientists holding at least an M.D., D.O., Pharm.D. and/or Ph.D. degree may apply. Consortiums are three or more institutions collaborating on a grant-supported research project. The success of the project depends on the unique contributions of each collaborating institution. A letter of support for each collaborative institution should be submitted detailing their unique contribution to the project.

Due Date: Letter of Intent Due: September 14, 2026 by 2:30pm CST

Application Assistance: Washington University faculty may reach out to Batool Akhtar-Zaidi in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: These grants are designed to provide seed funding for a new idea that may not have preliminary data but for which a strong case can be made for the potential impact for children, adolescents and young adults battling cancer. The priority area for this grant is to fund a novel idea for innovative research that could lead to advanced studies, better delivery of treatment or clinical translation.

Max Amount and Period: $50,000 for 1 year

Eligibility: Applicants conducting pediatric cancer research as a clinical fellow in pediatric hematology/oncology and/or postdoctoral research fellow may apply. Applicants must hold at least an M.D., D.O., Pharm.D. or Ph.D. degree and be conducting research after the first year of their fellowship. Applicants with all academic ranks, Instructor to Professor, and research scientists holding at least an M.D., D.O., Pharm.D. and/or Ph.D. degree may apply.

Due Date: Letter of Intent Due: September 14, 2026 by 2:30pm CST

Application Assistance: Washington University faculty may reach out to Batool Akhtar-Zaidi in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: Young Investigator Awards aim to attract early career faculty with original ideas into the field of melanoma, thereby recruiting and supporting the next generation of melanoma research leaders. Awardees will be provided with funding to accomplish innovative and original, preclinical, translational, and/or early clinical research projects. Young Investigators are scientists within the first five years of their first academic faculty appointment. A mentorship commitment from a senior investigator at the applicant’s institution is required.

Max Amount and Period: $255,000 over 3 years

Eligibility: Applicants must hold an SSO membership at the time of application and must be within the first five years of their first independent, full-time academic faculty appointment, at the level of Assistant Professor (or equivalent position); Applicants must designate at least one Mentor who is an established investigator at the same institution who will ensure that adequate support and guidance are provided for successful completion of the proposed research project and provide career mentorship. At least one Mentor with expertise in melanoma research is strongly advised; Applicants do not have to be on a tenure-track; however, fellows or others who are in training positions are not eligible to apply; Applicants who are in research support positions are not eligible to apply.

Due Date: Eligibility Checklist and Biosketch Due: September 14, 2026 at 4pm CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: Young Investigator Awards aim to attract early career faculty with original ideas into the field of melanoma, thereby recruiting and supporting the next generation of melanoma research leaders. Awardees will be provided with funding to accomplish innovative and original, preclinical, translational, and/or early clinical research projects. Young Investigators are scientists within the first five years of their first academic faculty appointment. A mentorship commitment from a senior investigator at the applicant’s institution is required. All Young Investigator applicants must have their eligibility confirmed prior to submitting an application. Applicants must upload the Applicant Eligibility Checklist and their biosketch in Proposal Central using the LOI function in the Young Investigator Award by 5:00 pm ET on September 14, 2026.

Max Amount and Period: $255,000 over 3 years

Eligibility: Applicants must be within the first five years of their first independent, full-time academic faculty appointment, at the level of Assistant Professor (or equivalent position); Applicants must designate at least one Mentor who is an established investigator at the same institution who will ensure that adequate support and guidance are provided for successful completion of the proposed research project and provide career mentorship. At least one Mentor with expertise in melanoma research is strongly advised; Applicants do not have to be on a tenure-track; however, fellows or others who are in training positions are not eligible to apply; Applicants who are in research support positions are not eligible to apply.

Due Date: Eligibility Checklist and Biosketch Due: September 14, 2026 at 4pm CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The A2C Grant is designed to provide integrated grant funding and expert advisory resources to investigator teams whose ovarian cancer-specific biomarkers have achieved a defined level of clinical readiness as measured by the National Cancer Institute’s Early Detection Research Network (EDRN) five-phase biomarker development framework. These advisory resources strengthen translational decision-making, de-risk development pathways, and better position projects for successful clinical advancement and external funding.

Max Amount and Period: $1M over 2 years

Eligibility: Applicants must be at the Assistant Professor level or higher. See RFA for full scientific project guidance.

Due Date: Letter of Intent Due: September 1, 2026

Application Assistance: Washington University faculty may reach out to Julie Potter Najem in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The objective of this AGA Research Foundation Pilot Research Award is to provide funds for gastroenterology or hepatology to early career investigators to help establish their research careers or to support projects that represent new research directions for established investigators.

Max Amount and Period: $40,000 for 1 year

Eligibility: Applicants for this award must hold an MD, PhD and/or equivalent degree (e.g., MBBS, MBChB, DO) and a full-time faculty or equivalent position at an institution in North America (United States, Canada or Mexico). AGA membership is required at the time of application submission. Applicants performing any type of research (basic, translational, clinical) relevant to digestive disorders are eligible to apply. Applicants who are physician-scientists, female or from racial/ethnic groups underrepresented in biomedical research are strongly encouraged to apply.

Due Date: September 15, 2026

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The objective of this AGA Research Foundation award is to provide supplemental funding to early career investigators who have existing career development awards and are conducting research relevant to the pathogenesis, prevention, diagnosis or treatment of digestive cancer.

Max Amount and Period: $40,000 for 1 year

Eligibility: Applicants must hold an NIH K series (e.g., K01, K08, K23, K99, R00) or other federal or non-federal career development award of at least four years’ duration. You must have at least one year remaining on the award on April 1, 2026. Applicants may not hold an R01 or equivalents such as a VA Merit award. Candidates for this award must hold an MD, PhD and/or equivalent degree (e.g., MB, ChB, MBBS, DO). Applicants must hold a full-time faculty or equivalent position at an institution in North America (United States, Canada and Mexico). Applicants must classify as “early career” according to the following criteria:
• MD applicants are considered “early career” if no more than seven years have elapsed following the completion of clinical training (GI fellowship or its equivalent) at the start date of this award (i.e., April 2027).
• PhD applicants are considered “early career” if no more than seven years have elapsed following the awarding of the PhD degree and the start date of this award (i.e., April 2027).
• AGA membership is required at the time of application submission.

Due Date: September 15, 2026

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The objective of this AGA Research Foundation award is to support an established investigator in the field of gastric cancer research working to enhance our fundamental understanding of gastric cancer pathobiology or approaches to prevent, treat or cure gastric cancer.

Max Amount and Period: $100,000 over 2 years

Eligibility: Applicants must be established as an independent investigator in the field of gastric biology.
• MD applicants are considered “established” if seven or more years have elapsed following the completion of clinical training (GI fellowship or its equivalent) at the start date of this award (i.e., April 2027).
• PhD applicants are considered “established” if seven or more years have elapsed following the awarding of the PhD degree and the start date of this award (i.e., April 2027).
• Applicants for this award must hold an MD, PhD and/or equivalent degree (e.g., MBBS, MBChB, DO).
• Applicants must hold a full‐time faculty or equivalent position at an institution in North America (United States, Canada and Mexico).
• AGA membership is required at the time of application submission.

Due Date: September 15, 2026

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: CAMS is a highly competitive program that provides $700,000 in support over five years for physician scientists (M.D., D.O., D.V.M., V.M.D., D.D.S.), who are committed to an academic career, to bridge postdoctoral/fellowship training and the early years of faculty service. Proposals must be focused on basic biomedical, disease oriented, or translational research. Proposals in health services research or involving large-scale clinical trials are not eligible.

Max Amount and Period: $700,000 over 5 years

Eligibility: Applicants are required to complete a pre-application eligibility check within ProposalCentral by 9/15. Only upon completion and confirmed eligibility can the full application be accessed. Candidates must hold an M.D., D.D.S., D.V.M., V.M.D., or D.O. degree. Candidates must have completed clinical training (residency or fellowship) and be board-eligible by the award start date. Candidates who hold a junior faculty appointment (Lecturer, Clinical Lecturer, Assistant Professor nontenure track, etc.) may be eligible and are required to determine eligibility via the eligibility check quiz prior to applying. Candidates who hold non-tenure track faculty appointments and have been awarded an NIH R01 or Early Independence Investigator award(s), including NIH K99/R00 or NIH DP5 award, are ineligible.

Due Date: Eligibility Checklist Due: September 15, 2026 at 2pm

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: Studies considered for Pfizer support should address key clinical and scientific gaps in the use of brentuximab vedotin in AITL and PTCL-NOS irrrespective of CD30 expression, with a focus on evaluating the safety and efficacy of novel brentuximab vedotin–based combinations with therapies available for PTCL treatment that are supported by a clear scientific rationale grounded in mechanism of action and/or disease biology.

Max Amount and Period: $500,000 over 3 years

Eligibility: The PI must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy, Physiotherapy, or Social Work. Applicants must disclose whether artificial intelligence (AI) tools were used in the preparation of their grant application. If AI tools were used, applicants should briefly identify the tool(s), describe how they were used (e.g., drafting, editing, summarization, content creation, etc.), and explain how AI-assisted outputs were reviewed and validated. Use of AI tools does not disqualify an application; however, applicants remain fully responsible for the accuracy, originality, and compliance of all submitted content. Failure to disclose the use of AI tools may result in disqualification of the application.

Due Date: September 17, 2026 at 10:pm

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This opportunity funds high-risk, high-reward translational ideas with a clear pathway to clinical impact. All projects must show how technology and computational approaches are a central driver of translational impact. Every funded project must contribute to and draw from a shared, harmonized data ecosystem and demonstrate a clear technology integration plan.

Max Amount and Period: $150,000 for 1 year

Eligibility: Investigators applying AI/ML, computational modeling, or data science to existing federated datasets; also open to bold, first-in-field hypotheses from early-stage investigators or new directions.

Due Date: Letter of Intent Due: September 18, 2026 

Application Assistance: Washington University faculty may reach out to Batool Akhtar-Zaidi in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This opportunity funds projects using existing data advancing toward preclinical or clinical translation where applicable, with a patient outcome validation plan. All projects must show how technology and computational approaches are a central driver of translational impact. Every funded project must contribute to and draw from a shared, harmonized data ecosystem and demonstrate a clear technology integration plan.

Max Amount and Period: $300,000 over 2 years

Eligibility: Researchers with validated models or pipelines, and established teams with preliminary data, ready to scale toward clinical readiness. Early-career investigators with strong supporting data are also encouraged to apply.

Due Date: Letter of Intent Due: September 18, 2026 

Application Assistance: Washington University faculty may reach out to Batool Akhtar-Zaidi in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This opportunity funds multi-investigator, crossinstitutional programs addressing a major unmet translational challenge with clinical integration. All projects must show how technology and computational approaches are a central driver of translational impact. Every funded project must contribute to and draw from a shared, harmonized data ecosystem and demonstrate a clear technology integration plan.

Max Amount and Period: $600,000 over 3 years

Eligibility: Multi-site consortia pairing computational/data-science with clinical sites.

Due Date: Letter of Intent Due: September 18, 2026 

Application Assistance: Washington University faculty may reach out to Batool Akhtar-Zaidi in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The award is intended to support highly promising investigators with stellar track records of accomplishment, who have the potential to advance the field of lung disease science. Successful applicants are investigators with evidence of prior excellence and productivity in the early stages of their careers; applicants must have held a K or R type award within five years preceding their application for this Lung Association award.

Max Amount and Period: $150,000 over 2 years

Eligibility: The applicant must hold a doctoral degree and have a full-time faculty or professional appointment equivalent with demonstrated institutional commitment (salary support, research space as evidenced by a Department Chair or equivalent letter) in a recognized academic or other not- for- profit research institution. The applicant must have held a K or R level grant in the 5 years preceding their application for this Lung Association award. Individuals who have been Pl on three or more large federal research grants (even those with multiple PIs) in their career are NOT eligible to apply.

Due Date: Letter of Intent Due: September 18, 2026 at 10:59pm CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This opportunity is intended to promote the development of innovative concepts and approaches, which will ultimately significantly improve the morbidity and mortality of lung cancer. The approach might be through basic biology, including host and tumor genetics, or focus on screening, prevention, diagnosis, and treatment.

Max Amount and Period: $200,000 over 2 years

Eligibility: The applicant must hold a doctoral degree, have a full-time faculty appointment or professional appointment at an academic institution (or equivalent in research institutions not formally associated with a university), and have completed a training fellowship. Applicants may be at any level of research experience; must be independent, self-directed researchers for whom their institution must provide space and other resources customary for independent investigators.

Due Date: Letter of Intent Due: September 18, 2026 at 10:59pm CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

WashU has been invited to submit up to 3 applicants for this award.
Additional Details

RFP Snapshot: The W. M. Keck Foundation awards grants of up to $1.3 million in support of high-risk, basic science projects that push the edge of the field, present unconventional approaches to intractable problems, or challenge the prevailing paradigm. These research projects should have strong evidence that they cannot be funded by federal grants due to their high-risk nature.

Max Amount and Period: $1.3M over 3 years

Eligibility: Senior, mid-, and early career investigators are encouraged to apply.

Info Webinar: WashU is hosting an informational webinar on Tuesday, September 1 at 3 P.M. Amy Smith and Amanda King are partnering with James Friend, PhD, to discuss the changes and other helpful information.

If you wish to attend the webinar, you must register using this link. 

Due Date: Internal Competition Materials Due: September 21, 2026 at 11:59pm CST

WashU has been invited to submit 1 applicant for this award.
Additional Details

RFP Snapshot: These grants are for specific two-year research projects which are hypothesis driven and may be either laboratory, clinical, or epidemiological in nature.

Max Amount and Period: $200,000 over 2 years

Eligibility: Applicants should hold a Ph.D., M.D., or D.O. degree in a field of research specialty by the date the award becomes effective. Applicants must be employed by an academic or non-profit research institution or laboratory based in the United States.

Due Date: Internal Competition Materials Due: September 21, 2026 at 11:59pm CST

Additional Details

RFP Snapshot: The Conquer Cancer Research Professorship in Ovarian Cancer provides flexible funding to outstanding full professors based at U.S. academic medical centers who have made significant contributions in ovarian cancer research and are dedicated to training the next generation of oncology leaders. The award may be used at the discretion of the awardee to support their overall research activities.

Max Amount and Period: $500,000 over 5 years

Eligibility: Applicant must be a physician (MD, DO, or international equivalent) with a full-time faculty appointment in a clinical department at an academic medical center in the United States. They must currently hold the rank of Full Professor (or equivalent) at an academic medical center. If applicant does not hold the rank of full professor, but meets all other eligibility criteria, they must provide written explanation of why their current rank at their institution should be considered equivalent. They must have made significant contributions in the area of ovarian cancer research and lead a research team in conducting research on ovarian cancer. Be serving as a research mentor to researcher(s) in training and/or junior faculty and must be planning to continue to provide leadership and mentoring in the area of ovarian cancer research throughout the award period. Mentees must be enrolled in an approved oncology subspecialty training program or in the first three years of faculty appointment. Applicant must be a current ASCO member or submit a membership application with the grant application. To apply for new membership, or to renew an existing membership, visit asco.org/membership. Expect to spend 75% of time during the award period dedicated to research (applies to total research, not just the proposed project), including leading a team of researchers (in the lab and/or clinic) and mentoring junior faculty and trainees on ovarian cancer research

Due Date: Letter of Intent Due: September 23, 2026 by 10:59pm CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: Blood Cancer United created the Academic Clinical Trials Program (ACT) to support investigator-initiated clinical trials (IITs) that address unmet medical needs in blood cancer, recognizing that academic research may address clinical benefit needs that sometimes diverge from commercial development pathways. This program focuses on hematologic malignancies and related pre-malignant conditions, seeking truly novel advances and highly innovative approaches. Novel biologic or chemical experimental agents, either as single agents or in combination are of high interest. The primary focus will be Phase 1 or 2 trials positioned to begin enrolling patients within 3-6 months of the October 1, 2027, award start. Investigators conducting existing trials, indication expansion trials, or additions of new cohorts are welcome to apply; such trials should focus on one of the areas of potential interest.

Max Amount and Period: $1M over 3 years

Eligibility: Applicants must hold a medical degree (MD or international equivalent). Other advanced degrees (OD, PharmD, PhD) will be considered. Only independent research investigators are eligible; clinical fellows, residents, postdoctoral fellows, and instructors are not eligible. Applicant must be an established investigator with 3+ years in an independent faculty appointment and have demonstrated experience in organizing, managing, and implementing clinical trials while protecting participant rights and welfare.

Due Date: Letter of Intent Due: September 29, 2026 by pm CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The International Development and Education Award (IDEA) provides support for early-career oncology physicians in low- and middle-income countries and facilitates the sharing of knowledge between these oncologists and ASCO members. The program pairs IDEA Recipients with a leading ASCO member Mentor, and enables Recipients to attend the ASCO Annual Meeting, participate in a post-Meeting visit to their Mentor’s institution, and develop long-term relationships to improve cancer care in their countries and inform ASCO programs in developing countries.

Max Amount and Period: Awardee is paired with an ASCO member mentor; receives registration, lodging, and travel for the ASCO Annual Meeting; registration, lodging, and travel for a visit to their mentor’s institution; $285 towards expenses associated with obtaining a U.S. B1/B2 visa and mandatory travel/medical insurance; and 3 years of complimentary membership with ASCO.

Eligibility: Applicant must have a current passport that expires AFTER December 2027. Applicants must be a current resident of a country classified by the World Bank as Low-Income, Lower Middle-Income, or Upper-Middle-Income, and have limited resources to attend the ASCO Annual Meeting (see APPENDIX B for a list of countries). As of June 1, 2027, applicants cannot have completed more than one academic year of “formal training” (for instance, attended medical school, participated in internships, fellowships, or residency programs) in a country classified by the World Bank as High-Income (see APPENDIX B for a list of countries). Applicants must be physicians and members of ASCO. Applicants who are not already members of ASCO must submit a membership application in order to be considered for the IDEA program. Applicants should be within ten years of graduating from their oncology training program. Therefore, applicants must have completed their oncology training in June 2017 or more recently.

Due Date: September 30, 2026 by 10:59pm CST

Additional Details

RFP Snapshot: The International Development and Education Award in Palliative Care (IDEA-PC) provides medical education in palliative care, assists with career development, and helps establish strong relationships with leading members in the field of palliative care who serve as scientific Mentors to each recipient. IDEA and IDEA-PC Recipients are expected to share the knowledge and training they receive through the program with colleagues in their home countries once they return.

Max Amount and Period: Awardee is paired with an ASCO member mentor; receives registration, lodging, and travel for the ASCO Annual Meeting; registration, lodging, and travel for a visit to their mentor’s institution; $285 towards expenses associated with obtaining a U.S. B1/B2 visa and mandatory travel/medical insurance; and 3 years of complimentary membership with ASCO.

Eligibility: Applicant must have demonstrated interest in integrating palliative and supportive care into their institution. This may be shown by attending courses on the topic, participating in related clinical activities, published articles, etc. Applicant must have a current passport that expires AFTER December 2027. Applicants must be a current resident of a country classified by the World Bank as Low-Income, Lower Middle-Income, or Upper-Middle-Income, and have limited resources to attend the ASCO Annual Meeting (see APPENDIX B for a list of countries). As of June 1, 2027, applicants cannot have completed more than one academic year of “formal training” (for instance, attended medical school, participated in internships, fellowships, or residency programs) in a country classified by the World Bank as High-Income (see APPENDIX B for a list of countries). Applicants must be physicians and members of ASCO. Applicants who are not already members of ASCO must submit a membership application in order to be considered for the IDEA program. Applicants should be within ten years of graduating from their oncology training program. Therefore, applicants must have completed their oncology training in June 2017 or more recently.

Due Date: September 30, 2026 by 10:59pm CST

Additional Details

RFP Snapshot: This funding call invites proposals that primarily aim to design, validate, and test ground-breaking interventions to treat DMG resulting in a step-change of long-term survival and high quality of life for CAYA patients.

Max Amount and Period: $1M over 2 years

Eligibility: Team Lead, Co-Lead, and Principal must all have a doctoral or medical degree and be senior, independent investigators. The TL and TC are expected to each dedicate at least 20 percent (or 40 percent combined) of their time and effort to the Team research project. No Team will have more than one Key Personnel (TL, TC, or TP) from any given institution at the time of their initial appointment on the Team. No more than two Key Personnel may be from affiliated institutions.

Due Date: September 30, 2026 by 10:59pm CST

Application Assistance: Washington University faculty may reach out to Batool Akhtar-Zaidi in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This grant is open to all gynecologic cancers.

Max Amount and Period: $50,000 for 1 year

Eligibility: Applicants must be Society of Gynecologic Oncology (SGO) members or apply with an SGO-member co-investigator or sponsor. Priority is given to early-career and junior investigators—generally Assistant Professors and below within seven years of their first faculty appointment—who have not received DoD, ACS, or NCI funding in the proposed research area. Full professors are not eligible, and only one application per applicant is permitted.

Due Date: Letter of Intent Due: October 1, 2026 at 10:59pm CST

Application Assistance: Washington University faculty may reach out to Julie Potter Najem in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This grant application invites proposals for research projects that incorporate personalized Molecular Residual Disease testing (MRD) to advance the management of gynecologic cancers. Projects should focus on innovative uses of MRD in gynecologic cancers.

Max Amount and Period: $50,000 for 1 year

Eligibility: Applicants must be Society of Gynecologic Oncology (SGO) members or apply with an SGO-member co-investigator or sponsor. Priority is given to early-career and junior investigators—generally Assistant Professors and below within seven years of their first faculty appointment—who have not received DoD, ACS, or NCI funding in the proposed research area. Full professors are not eligible, and only one application per applicant is permitted.

Due Date: Letter of Intent Due: October 1, 2026 at 10:59pm CST

Application Assistance: Washington University faculty may reach out to Julie Potter Najem in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This grant is open to all gynecologic cancers.

Max Amount and Period: $50,000 for 1 year

Eligibility: Applicants must be Society of Gynecologic Oncology (SGO) members or apply with an SGO-member co-investigator or sponsor. Priority is given to early-career and junior investigators—generally Assistant Professors and below within seven years of their first faculty appointment—who have not received DoD, ACS, or NCI funding in the proposed research area. Full professors are not eligible, and only one application per applicant is permitted.

Due Date: Letter of Intent Due: October 1, 2026 at 10:59pm CST

Application Assistance: Washington University faculty may reach out to Julie Potter Najem in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot:The Amy Krouse Rosenthal Foundation Ovarian Cancer Early Detection grant supports research in early detection and recurrence biomarker development.

Max Amount and Period: $72,500 for 1 year

Eligibility: Applicants must be Society of Gynecologic Oncology (SGO) members or apply with an SGO-member co-investigator or sponsor. Priority is given to early-career and junior investigators—generally Assistant Professors and below within seven years of their first faculty appointment—who have not received DoD, ACS, or NCI funding in the proposed research area. Full professors are not eligible, and only one application per applicant is permitted.

Due Date: Letter of Intent Due: October 1, 2026 at 10:59pm CST

Application Assistance: Washington University faculty may reach out to Julie Potter Najem in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This award is designed to support promising fellows and early career faculty pursuing innovative research in ovarian cancer. The grant aims to foster the development of the next generation of investigators and provide critical support during the transition to research independence. Projects may encompass basic, translational, clinical, or population-based research relevant to the prevention, diagnosis, treatment, or outcomes of gynecologic cancers with additional consideration for proposals with emphasis on DNA damage response (DDR), immuno-oncology (IO), and antibody-drug conjugates (ADCs).

Max Amount and Period: $50,000 for 1 year

Eligibility: Applicants must be Society of Gynecologic Oncology (SGO) members or apply with an SGO-member co-investigator or sponsor. This is open to promising fellows and early career faculty pursuing innovative research in ovarian cancer. Only one application per applicant is permitted.

Due Date: Letter of Intent Due: October 1, 2026 at 10:59pm CST

Application Assistance: Washington University faculty may reach out to Julie Potter Najem in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This award is designed to support promising fellow and early career faculty pursuing innovative research in ovarian cancer. The grant aims to foster the development of the next generation of investigators and provide critical support during the transition to research independence. Projects may encompass basic, translational, clinical, or population-based research relevant to the prevention, diagnosis, treatment, or outcomes of gynecologic cancers. Applicants should demonstrate a strong commitment to a career in gynecologic oncology research and describe how the proposed work will advance their development as an independent investigator.

Max Amount and Period: $75,000 for 1 year

Eligibility: Applicants must be Society of Gynecologic Oncology (SGO) members or apply with an SGO-member co-investigator or sponsor. This is open to promising fellows and early career faculty pursuing innovative research in ovarian cancer. Only one application per applicant is permitted.

Due Date: Letter of Intent Due: October 1, 2026 at 10:59pm CST

Application Assistance: Washington University faculty may reach out to Julie Potter Najem in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This grant is focused on early detection of ovarian cancer. The National Ovarian Cancer Coalition (NOCC) supports their mission to save lives through the prevention and cure of ovarian cancer in part by donating to ovarian cancer research. Since their founding in 1991, NOCC has become an important national advocate for patients and families fighting ovarian cancer. This is the NOCC’s sixth year supporting the FWC Research Grants program.

Max Amount and Period: $50,000 for 1 year

Eligibility: Applicants must be Society of Gynecologic Oncology (SGO) members or apply with an SGO-member co-investigator or sponsor. Priority is given to early-career and junior investigators—generally Assistant Professors and below within seven years of their first faculty appointment—who have not received DoD, ACS, or NCI funding in the proposed research area. Full professors are not eligible, and only one application per applicant is permitted.

Due Date: Letter of Intent Due: October 1, 2026 at 10:59pm CST

Application Assistance: Washington University faculty may reach out to Julie Potter Najem in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The National Ovarian Cancer Coalition is proud to announce their one-year grant to support innovative research focused on addressing different health outcomes in ovarian cancer prevention, diagnosis, treatment, and survivorship. Priority will be given to projects that explore the impact of social determinants of health and improve access to care in ovarian cancer research.

Max Amount and Period: $50,000 for 1 year

Eligibility: Applicants must be Society of Gynecologic Oncology (SGO) members or apply with an SGO-member co-investigator or sponsor. Priority is given to early-career and junior investigators—generally Assistant Professors and below within seven years of their first faculty appointment—who have not received DoD, ACS, or NCI funding in the proposed research area. Full professors are not eligible, and only one application per applicant is permitted.

Due Date: Letter of Intent Due: October 1, 2026 at 10:59pm CST

Application Assistance: Washington University faculty may reach out to Julie Potter Najem in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot:This award supports innovative research to improve outcomes for patients with advanced ovarian cancer complicated by malignant bowel obstruction, a devastating condition that can limit or preclude further cancer-directed therapy. The award also encourages innovative therapeutic, procedural, supportive-care, or multidisciplinary strategies that prevent or relieve obstruction and enable patients to receive or continue effective cancer-directed treatment.

Max Amount and Period: $100,000 for 1 year

Eligibility: Applicants must be Society of Gynecologic Oncology (SGO) members or apply with an SGO-member co-investigator or sponsor. Priority is given to early-career and junior investigators—generally Assistant Professors and below within seven years of their first faculty appointment—who have not received DoD, ACS, or NCI funding in the proposed research area. Full professors are not eligible, and only one application per applicant is permitted.

Due Date: Letter of Intent Due: October 1, 2026 at 10:59pm CST

Application Assistance: Washington University faculty may reach out to Julie Potter Najem in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This grant supports innovative molecular profiling of endometriosis to identify dysregulated pathways that advance understanding of disease biology and reveal actionable targets for therapeutic development. The goal is to translate these discoveries into more precise and effective treatments that can augment and ultimately may reduce or replace the need for surgical intervention. The grant also seeks to deepen understanding of the molecular and precancerous linkages between endometriosis and endometriosis-associated ovarian cancers, particularly endometrioid and clear cell ovarian cancer.

Max Amount and Period: $100,000 for 1 year

Eligibility: Applicants must be Society of Gynecologic Oncology (SGO) members or apply with an SGO-member co-investigator or sponsor. Priority is given to early-career and junior investigators—generally Assistant Professors and below within seven years of their first faculty appointment—who have not received DoD, ACS, or NCI funding in the proposed research area. Full professors are not eligible, and only one application per applicant is permitted.

Due Date: Letter of Intent Due: October 1, 2026 at 10:59pm CST

Application Assistance: Washington University faculty may reach out to Julie Potter Najem in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This award is designed to support promising fellows and early career faculty pursuing innovative research in endometrial cancer. The grant aims to foster the development of the next generation of investigators and provide critical support during the transition to research independence. Projects may encompass basic, translational, clinical, or population-based research relevant to the prevention, diagnosis, treatment, or outcomes of gynecologic cancers. Applicants should demonstrate a strong commitment to a career in gynecologic oncology research and describe how the proposed work will advance their development as an independent investigator. Priority will be given to innovative projects with the potential to generate preliminary data and catalyze future research and extramural funding.

Max Amount and Period: $75,000 for 1 year

Eligibility: Applicants must be Society of Gynecologic Oncology (SGO) members or apply with an SGO-member co-investigator or sponsor. This is open to promising fellows and early career faculty pursuing innovative research in endometrial cancer. Only one application per applicant is permitted.

Due Date: Letter of Intent Due: October 1, 2026 at 10:59pm CST

Application Assistance: Washington University faculty may reach out to Julie Potter Najem in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This grant supports research to improve outcomes for patients with high-risk and poor-prognosis endometrial cancer, including serous tumors and sarcomas. Priority will be given to studies that integrate precision-based tools and molecular diagnostics including ctDNA, genomic and gene-expression profiling, proteomics, and other emerging technologies into clinical and translational research to improve risk stratification, guide treatment selection, monitor therapeutic response, and identify mechanisms of resistance.

Max Amount and Period: $50,000 for 1 year

Eligibility: Applicants must be Society of Gynecologic Oncology (SGO) members or apply with an SGO-member co-investigator or sponsor. Priority is given to early-career and junior investigators—generally Assistant Professors and below within seven years of their first faculty appointment—who have not received DoD, ACS, or NCI funding in the proposed research area. Full professors are not eligible, and only one application per applicant is permitted.

Due Date: Letter of Intent Due: October 1, 2026 at 10:59pm CST

Application Assistance: Washington University faculty may reach out to Julie Potter Najem in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This grant focuses on understanding FRα expression levels throughout the disease trajectory of ovarian or endometrial cancer. Priority will be given to supporting research that enhances our understanding of folate receptor alpha (FRα) expression levels throughout the progression of ovarian and/or endometrial cancer. These insights could inform treatment decision-making and enable more precise patient stratification, ultimately improving clinical outcomes. Representation of underserved populations will be a highly valued feature in the review of submissions.

Max Amount and Period: $50,000 for 1 year

Eligibility: Applicants must be Society of Gynecologic Oncology (SGO) members or apply with an SGO-member co-investigator or sponsor. Priority is given to early-career and junior investigators—generally Assistant Professors and below within seven years of their first faculty appointment—who have not received DoD, ACS, or NCI funding in the proposed research area. Full professors are not eligible, and only one application per applicant is permitted.

Due Date: Letter of Intent Due: October 1, 2026 at 10:59pm CST

Application Assistance: Washington University faculty may reach out to Julie Potter Najem in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This grant will support the development of AI enabled web-based risk stratification tools to identify patients who may benefit from enhanced screening, risk reducing interventions, and preventative strategies for endometrial cancer. By integrating clinical and patient-specific risk factors with advanced imaging, including MRI and ultrasound, this project aims to improve individualized risk assessment, facilitate early detection and prevention, expand access to innovative diagnostic strategies, and improve outcomes for women in our underserved communities.

Max Amount and Period: $50,000 for 1 year

Eligibility: Applicants must be Society of Gynecologic Oncology (SGO) members or apply with an SGO-member co-investigator or sponsor. Priority is given to early-career and junior investigators—generally Assistant Professors and below within seven years of their first faculty appointment—who have not received DoD, ACS, or NCI funding in the proposed research area. Full professors are not eligible, and only one application per applicant is permitted.

Due Date: Letter of Intent Due: October 1, 2026 at 10:59pm CST

Application Assistance: Washington University faculty may reach out to Julie Potter Najem in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This grant is open to all gynecologic cancers except ovarian cancer. This grant supports innovative research to advance the early detection of gynecologic cancers through minimally invasive, accessible, and cost-effective approaches. Priority will be given to the discovery and validation of diagnostic biomarkers using readily obtainable biospecimens, including urine, vaginal or cervical samples, and blood, as well as emerging sampling technologies. The goal is to develop accurate, scalable screening strategies that enable earlier diagnosis and can be broadly implemented across diverse populations and care settings.

Max Amount and Period: $50,000 for 1 year

Eligibility: Applicants must be Society of Gynecologic Oncology (SGO) members or apply with an SGO-member co-investigator or sponsor. Priority is given to early-career and junior investigators—generally Assistant Professors and below within seven years of their first faculty appointment—who have not received DoD, ACS, or NCI funding in the proposed research area. Full professors are not eligible, and only one application per applicant is permitted.

Due Date: Letter of Intent Due: October 1, 2026 at 10:59pm CST

Application Assistance: Washington University faculty may reach out to Julie Potter Najem in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: Established in memory of Wendy R. Brewster, MD, PhD a beloved national leader, mentor, and advocate in gynecologic oncology, this grant supports fellows and physicians within the first two years following fellowship. Funding provides protected nonclinical research time and research-related support to generate preliminary data and advance future independent investigation.

Max Amount and Period: $25,000 for 1 year

Eligibility: Applicants must be Society of Gynecologic Oncology (SGO) members or apply with an SGO-member co-investigator or sponsor. Applicants must be fellows or physicians demonstrating success in the field of gynecologic oncology with their research in cervical or endometrial cancer research within the first two years following fellowship as they launch careers as physician-investigators. Only one application per applicant is permitted.

Due Date: Letter of Intent Due: October 1, 2026 at 10:59pm CST

Application Assistance: Washington University faculty may reach out to Julie Potter Najem in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This award, supported by Dornier MedTech, supports established urology researchers navigating critical financial shortages. Its goal is simple but impactful: to sustain urologic researchers who are at risk due to gaps between major grants, required post-peer review revisions, or unexpected laboratory setbacks. Proposals should be focused on research at the preclinical research stage or later, i.e. candidate targets and/or interventions should already have been identified. The project must aim to deliver interventions to patients in a clinical research study within 18-24 months of the project start.

Max Amount and Period: $60,000

Eligibility: Applicants must be independently managing their research projects, even if based within a larger laboratory. Early career investigators are eligible only if they are no longer under formal mentorship, such as transitioning to an R-level award. This ensures the funds go to those who are actively involved in sustained, independent research but need a timely boost to stay competitive.

Due Date: October 5, 2026 at 10:59pm CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The CureSearch for Children’s Cancer Acceleration Initiative (AI) advances pediatric cancer research worldwide to address the most challenging problems facing childhood cancer research in order to accelerate progress in the field toward a cure. CureSearch will review and fund promising research that addresses barriers in areas of high unmet need in pediatric cancer research. We support innovative, evidence-based translational and preclinical cancer research that has a high potential to improve therapeutic options through research pathways that are collaborative, interdisciplinary, and generate measurable results.

Max Amount and Period: $1M over 3 years

Eligibility: Applicants must be an MD, PhD, DO, or equivalent and be an independent investigators at any level of their career. For applicants seeking support of $500,000 or greater, a minimum committed effort of 10% from the PI is required.

Due Date: Letter of Intent Due: October 7, 2026 at 10:59pm CST

Application Assistance: Washington University faculty may reach out to Batool Akhtar-Zaidi in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This two-year award is funded by the Foundation for Peripheral Neuropathy and supports clinical or preclinical research in peripheral neuropathy. This grant targets early career researchers who are studying disease mechanisms, diagnosis, or treatment of peripheral neuropathy and whose research has potential relevance beyond peripheral neuropathy to other diseases.

Max Amount and Period: $150,000 over 2 years

Eligibility: Applicants must be research investigators with an MD, PhD, or equivalent terminal-level clinical or research degree. Applicants must have completed clinical residency or PhD on or after July 1, 2022. Applicants at accredited US and international institutions are eligible to apply. There is no citizenship requirement. Applicants must have at least 50% time dedicated to research (protected time).

Due Date: October 8, 2026 at 4pm CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The Conquer Cancer Career Development Award (CDA) provides funding to clinical investigators who have received their initial faculty appointment and are establishing an independent research career in clinical oncology. This is a mentored award, and the research project is conducted under the guidance of an experienced mentor in the proposed research area. For this year, there will be dedicated donor funding available for projects in Palliative/Supportive Care and Breast Cancer.

Max Amount and Period: $200,000 over 3 years

Eligibility: A physician (MD, DO, or international equivalent with explanation) working in any country. In the first to fourth year of a full-time primary faculty appointment in a clinical department at an academic medical institution at the time of grant submission. Faculty appointment may begin with the entry-level faculty position within the applicant’s institution. Have completed productive postdoctoral research and demonstrated the ability to undertake independent investigator-initiated clinical research. Be a current ASCO member or have submitted a membership application with the grant application. 50% of time to research. Applicants with concurrent federal career development awards (e.g., K23, K08, or any other type of career development award), career development awards from private foundations, and institutional training grants (T32, KL2/K12 or equivalent) are eligible to apply provided there are no scientific and budgetary overlaps. Applicants should not have been a Principal Investigator on any large project grants (e.g., R01 or international equivalent).

Due Date: October 8, 2026 at 10:59pm CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The Conquer Cancer Career Development Award (CDA) in Ovarian Cancer provides funding to clinical investigators who have received their initial faculty appointment and are establishing an independent research career focused on ovarian cancer. This is a mentored award, and the research project is conducted under the guidance of an experienced mentor in the proposed research area.

Max Amount and Period: $200,000 over 3 years

Eligibility: A physician (MD, DO, or international equivalent with explanation) working in any country. In the first to fourth year of a full-time primary faculty appointment in a clinical department at an academic medical institution at the time of grant submission. Faculty appointment may begin with the entry-level faculty position within the applicant’s institution. Have completed productive postdoctoral research and demonstrated the ability to undertake independent investigator-initiated clinical research in ovarian cancer. Be a current ASCO member or have submitted a membership application with the grant application. 50% of time to research. Applicants with concurrent federal career development awards (e.g., K23, K08, or any other type of career development award), career development awards from private foundations, and institutional training grants (T32, KL2/K12 or equivalent) are eligible to apply provided there are no scientific and budgetary overlaps. Applicants should not have been a Principal Investigator on any large project grants (e.g., R01 or international equivalent).

Due Date: October 8, 2026 by 10:59pm CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The intent of this RFP is to request proposals for the implementation of strategies that will support and measurably improve equitable delivery of guideline concordant care for patients with HER2+ GEA in the United States, including the administration of HER2 directed therapy as part of first line treatment. Proposals should describe the application of quality improvement standards to evaluate current adherence to treatment guidelines, evaluation of guideline-discordant care and measures to improve guideline-concordant care for patients with advanced HER2+ GEA.

Max Amount and Period: $125,000 over 2 years

Eligibility: Proposals must represent multi-disciplinary teams delivering care to GEA patients. Collaboration among healthcare centers and organizations, especially community care providers, is encouraged to foster interactive sharing of knowledge and expertise. Proposals should include collaboration with patient advocates, advocacy organizations, of other groups that can represent the perspective of GEA patients. Awards will be made only to eligible organizations and institutions. Individual healthcare professionals are not eligible to receive awards directly.

Due Date: October 15, 2026

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The intent of this RFP is to request proposals for the implementation of strategies that will support and measurably improve equitable delivery of guideline concordant molecular testing and care for pediatric and adult glioma in the United States. Proposals should describe the application of quality improvement standards to evaluate current adherence to treatment guidelines, evaluation of guideline-discordant care and measures to improve guideline-concordant testing and care for patients with glioma.

Max Amount and Period: $125,000 over 2 years

Eligibility: Proposals should represent multi-disciplinary teams delivering care to glioma patients. Collaboration among healthcare centers and organizations, especially community care providers, is encouraged to foster interactive sharing of knowledge and expertise. Proposals that include collaboration with patient advocates, advocacy organizations, of other groups that can represent the perspective of glioma patients, are encouraged. Awards will be made only to eligible organizations and institutions. Individual healthcare professionals are not eligible to receive awards directly.

Due Date: October 15, 2026

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The Scholar award is a subcategory of CDP that exists to support the career development of
early- to mid-stage independent investigators. This is not a project grant. Salary support is given to assist the Scholar in all their research activities. As such, all research activities of a funded Scholar are supported by the Scholar award. We ask for a description of your overall research program as part of your application, which aids in the evaluation process of your overall application package. However, any funded Scholar’s research is supported by the Scholar award, even if it is not directly related to the projects described in the original
application.

Max Amount and Period: $600,000 over 5 years

Eligibility: Applicants must be tenure-track, independent investigators holding at least an Assistant Professor position or equivalent. They must have started their first independent position no less than 4 years but not more than 8 years as of January 1 in the year of the award start date. They must have a total research program that is at least 75% focused on direct blood cancer research.

Due Date: Eligibility Affirmation Due: October 15, 2026 at 2pm CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The Scholar in Clinical Research award is a subcategory of CDP that exists to support the career development of early- to mid-stage independent investigators. This is not a project grant. Salary support is given to assist the Scholar in Clinical Research in all their research activities. As such, all research activities of a funded Scholar in Clinical Research are supported by the Scholar in Clinical Research award. We ask for a description of your overall research program as part of your application, which aids in the evaluation process of your overall application package. However, any funded research from a Scholar in Clinical Research
is supported by the Scholar in Clinical Research award, even if it is not directly related to the projects described in the original application.

Max Amount and Period: $600,000 over 5 years

Eligibility: Applicants must have substantial clinical training in blood cancer (greater than 1 year) and be tenure-track, independent investigators holding at least an Assistant Professor position or equivalent. They must have started their first independent position no less than 4 years but not more than 10 years as of January 1 in the year of the award start date. They must have a total research program that is at least 75% focused on direct blood cancer research.

Due Date: Eligibility Affirmation Due: October 15, 2026 at 2pm CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The Innovation Grant is designed to provide critical and significant seed funding for established researchers with a novel approach to pediatric oncology scientific investigation. Proposals should have clinical translation in view. This may represent a change in research direction and/or an innovative new idea that moves away from an investigator’s prior research but for which a strong case is made for the potential impact on childhood cancers.

Max Amount and Period: $250,000 over 2 years

Eligibility: Applicants may be MD, PhD, or MD/PhD and be appointed as faculty. They must have a track record of publication with at least one publication as a Senior Corresponding Author and funding productivity that demonstrates the project can be accomplished by the investigators. Must have at least one NIH R01 equivalent award in their career. Applicants must propose a ne research direction, not a continuation of ongoing funded research.

Due Date: Letter of Intent Due: October 15, 2026 at pm CST

Application Assistance: Washington University faculty may reach out to Batool Akhtar-Zaidi in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: MIB Agents is a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for our community of patients, families, medical professionals, researchers, and industry partners through programs, education, and research. The Hero Award is for any investigator with a compelling project that will Make It Better for osteosarcoma patients.

Max Amount and Period: $100,000 for 1 year

Eligibility: The principal investigator (PI) must be an independent investigator with experience in translational research. Academic ranks of Assistant Professor, Associate Professor, Professor, and research scientists with M.D., D.O., D.V.M., and/or Ph.D. degrees may apply.

Due Date: Letter of Intent Due: October 16, 2026

Application Assistance: Washington University faculty may reach out to Batool Akhtar-Zaidi in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: MIB Agents is a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for our community of patients, families, medical professionals, researchers, and industry partners through programs, education, and research. The Young Investigator Hope Award is open to any young investigator with a compelling project that will Make It Better for osteosarcoma patients.

Max Amount and Period: $50,000 for 1 year

Eligibility: At the time of the application due date (January 25, 2027), applicants must be within 5 years post-fellowship with experience in translational research. Academic rank may not exceed Assistant Professor. M.D., D.O., D.V.M., and/or Ph.D. degrees may apply. At the time of application or successful award, the applicant must not hold an NIH independent (R or P) Award. Institutional training grants (K12, T32) are permitted. A research mentor must be identified. The application must document the mentor’s involvement in experimental design and execution and describe a career development and training plan.

Due Date: Letter of Intent Due: October 16, 2026

Application Assistance: Washington University faculty may reach out to Batool Akhtar-Zaidi in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The Translational Research Program (TRP) was formed to enhance the transfer of basic research findings to clinical usefulness. The TRP Grant program is geared towards translational medicine for blood cancers. For this cycle, the sponsor will ONLY consider applications that adhere to the following guidelines:
• For small molecule compounds, the application must have in vivo proof of concept (POC) in appropriate mouse models. Alternatively, based on the mechanism of action, an in vitro POC with patient-derived samples may be considered.
• For cellular or immunotherapies, in vivo POC would make for a stronger application. We acknowledge, however, that depending on the type of therapy being developed, an in vitro POC may be more appropriate or necessary.

Max Amount and Period:$750,000 over 3 years

Eligibility: Applicants must hold a PhD, MD, DVM, or equivalent degree. Must be an established, independent investigator, defined as a scientist who has dedicated laboratory space, directly hires and supervises laboratory personnel (technicians, graduate students, postdocs, and staff scientists), and makes all decisions concerning research activities and use of the grant funds.

Due Date: Letter of Intent: October 16, 2026 by 2pm CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

WashU has been invited to submit 1 applicant for this award.
Additional Details

RFP Snapshot: The Vallee Scholar award recognizes that outstanding, young, independent investigators are the source for future advances in the biomedical sciences and wishes to provide flexible funding for basic research.

Max Amount and Period: $340,000 over 4 years

Eligibility: The candidate must have received PhD/MD or other professional degree within 12 years of the application deadline, and by the application date should have been in an independent research position (tenure track or equivalent) for six years or fewer. The Vallee Foundation has no restrictions on nominees having received other grant funding.

Due Date: Internal Competition Materials Due: October 19, 2026 at 11:59pm CST

WashU has been invited to submit up to 5 applicants for this award.
Additional Details

RFP Snapshot: The INSPIRE Research Challenge is aimed at Early Career Researchers (ECRs) and will prioritize innovative, bold, and creative proposals with the potential to catalyze rapid and impactful advances in cancer prevention, treatment and survivorship.

Max Amount and Period: $100,000 for 1 year

Eligibility: Applicants must be within 2–7 years full-time equivalent (FTE) working in research since the award date of their PhD or equivalent higher research degree. Applicants are expected to demonstrate conceptual independence from post-doctoral supervisors or mentor(s) and post-doctoral applicants must provide proof of support for their application from their current supervisor. Only one application per Principal Investigator per grant cycle is permitted. A maximum of five applications will be accepted from one institution in any one grant cycle.

Due Date: Internal Competition Materials Due: October 19, 2026 at 11:59pm CST

WashU has been invited to submit up to 1 applicant for this award.
Additional Details

RFP Snapshot: The Scholar (Career Development) Award is meant to help develop the independent research of highly qualified individuals early in their careers.

Max Amount and Period: $330,000 over 3 years (opportunity for two additional years of funding)

Eligibility: Applicants should hold a Ph.D., M.D., or D.O. degree in a field of research specialty by the date the award becomes effective. Applicants must be employed by an academic or non-profit research institution or laboratory based in the United States. Applicants must currently hold (for no longer than 7 years at the time the award begins), or will hold by start of the award, a title that is considered by the institution to be a full-time, faculty position.

Due Date: Internal Competition Materials Due: October 19, 2026 at 11:59pm CST

WashU has been invited to submit up to 1 applicant for this award.
Additional Details

RFP Snapshot: This award is meant to train researchers from low- and middle- income countries (as classified by the World Bank) to prepare them to fill specific stated needs in an area of childhood cancer research upon returning to their country of origin.

Max Amount and Period: $330,000 over 3 years (opportunity for two additional years of funding)

Eligibility: Applicants should hold a Ph.D., M.D., D.O., or international equivalent degree by the date the award becomes effective. Applicants must have completed a pediatric oncology fellowship or two (2) years of equivalent training. Applicants must commit to return to their country of origin upon completion of the training period at the sponsoring institution. A letter of support from the Institution of Origin is required.

Due Date: Internal Competition Materials Due: October 19, 2026 at 11:59pm CST

WashU has been invited to submit up to 1 applicant for this award.
Additional Details

RFP Snapshot: These grants are for specific one-year research projects which are hypothesis-driven and focus on areas related to survivorship and supportive care of children and adolescents with cancer.

Max Amount and Period: $50,000 for 1 year

Eligibility: Applications are accepted from Ph.D., D.N.P., M.D./D.O. holders.

Due Date: Internal Competition Materials Due: October 19, 2026 at 11:59pm CST

Additional Details

RFP Snapshot: The program seeks to support outstanding individuals committed to a career as a physician-scientist. This program aims to alleviate the Scholar’s financial stress and provide them with mentorship, institutional support, and the protected time necessary to generate data and publications. At the end of the support period, Scholars will be competitive for the NIH K08 and related awards, and be on the path to a successful career. The ideal applicant has completed most if not all clinical training, is currently focused on laboratory research, and seeks additional research support and protected time to be competitive for research career development awards and independent research funding.

Max Amount and Period: $100,000 over 2 years

Eligibility: Applicants must have an MD or equivalent degree (MD/PhDs and PhDs are NOT eligible). Must have completed most if not all clinical training and have at least 75% time (preferably more) devoted to basic science research. Surgeons and others with procedure-instensive specialties may propose a percent research time consistent with NIH guidelines (typically no less than 50%).Applicants must be eligble for mentored support, such as the K award. They must not already have a K award or related mentored or independent grant at the time of application, nor be the PI or co-PI on another significant extramural grant.

Due Date: October 19, 2026 

Additional Details

RFP Snapshot: The $25,000 award is designed to to advance the translation of new discoveries in cancer disease biology into small molecule therapeutics for the benefit of patients. The QuikSTART award is viewed as a “hand-up” to generate preliminary data to enable successful following-on funding (e.g., NCI, NIH, private foundation, commercial partnership), publication, and patent filing.

Max Amount and Period: $25,000

Eligibility: See RFA

Due Date: October 23, 2026 

Additional Details

RFP Snapshot: It aims to fund evidence-based interventional clinical trials (Phase I to II clinical trials are encouraged) in supportive care, specifically by investigators in their first to third year (at the time of the LOI deadline) of a full-time primary faculty appointment at an academic medical institution. This RFP is open to investigators worldwide.

Max Amount and Period:$245,000 over 4 years

Eligibility: Applicants are in their first to third year as of the LOI deadline. Applicants beyond year three due to parental leave, caregiving responsibilities, or part-time clinical appointments may be considered on a case-by-case basis and should provide justification in the application. Applicants have a full-time, primary academic appointment with a clinical position worldwide.

Due Date: October 30, 2026

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The purpose of the Dr. Robert F. Vizza Clinical Accelerator Initiative (CAI) is to advance the mission of the Lustgarten Foundation by accelerating the translation of research discoveries into clinical trials. Through the CAI, the Lustgarten Foundation will provide academic, clinical researchers the opportunity to propose science-driven concepts seeking to advance the development of new therapies for pancreatic cancer patients while furthering our understanding of disease biology.

Max Amount and Period: $1.5M to $2M over 3 years

Eligibility: Applicants must hold an M.D., D.M.D., D.V.M., Ph.D., or equivalent degree and have a faculty position or equivalent at a college, university, medical institution, or other research facility.

Due Date: Letter of Intent Due: November 2, 2026

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The RWJF Health Policy Fellows program provides the nation’s most comprehensive midcareer learning experience at the intersection of health, science, and policy in Washington, D.C. Fellows participate in the policy process at the federal level and leverage that leadership experience to promote policies, practices, and systems changes that advance the health of the nation.

Max Amount and Period: $175,000 over 1-2 years

Eligibility: The fellowship requires a full-time commitment with a minimum 12-month residence in Washington, D.C., which prepares individuals to influence the future of health and its drivers in the nation. Exceptional midcareer professionals from academic institutions, not-for-profit organizations, or government. Applicants must have earned an advanced degree (master’s or doctoral degree). In addition, applicants must have developed deep subject matter experience in a health- related discipline and have at least 10 years of full-time work experience. Examples include but are not limited to medicine; nursing; public health; law; dentistry; economics and other social sciences (especially disciplines related to factors that influence population health, such as housing, transportation, nutrition, employment, education, and environmental and community conditions); health services and social work/behavioral health; and other health professions.

Due Date: November 3, 2026 at 2pm CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: Pilot Awards support senior investigators who propose potentially transformative ideas that do not have extensive preliminary data but articulate a clear hypothesis and translational goals. Resources for such “high-risk, high-reward” projects are important to establish proof-of-concept, which may then leverage additional funding through more traditional avenues.

Max Amount and Period: $100,000 over 2 years

Eligibility: Applicants must hold a full-time faculty appointment at the level of Assistant Professor (or equivalent) or above. It is strongly recommended that Principal Investigators be beyond the first five years of their first faculty appointment.

Due Date: November 5, 2026 at 4pm CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The Core grants program funds early phase clinical trials (Phase 1 and 2) for cancers at renowned institutions around the world that have the potential to shift the paradigm for standard of care. We strive to fund treatment-based studies at the bedside, including all types of cancers.

Max Amount and Period: $200,000 to $1.5M over 2 to 5 years

Eligibility: Any investigator who is ready to conduct a novel, clinical trial in cancer research – one which will have an immediate impact on cancer patients.

Due Date: Letter of Intent Due: November 6, 2026 at Noon CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The Sarcoma Foundation of America Research Grants support investigators conducting pre-clinical, translational, and clinical research on the etiology, molecular biology, pathogenesis, diagnosis, and treatment of human sarcomas. This program supports our mission to fund research and increase awareness and advocacy for sarcoma patients and their families. The goal of the SFA grant program is to support research that results in improved therapeutic options for sarcoma patients. The SFA encourages applications from ALL areas of sarcoma research.

Max Amount and Period: $75,000 for 1 year

Eligibility: Applicants must be an MD, DO, PhD, or international equivalent, inside or outside the U.S., with the skills, knowledge, and resources necessary to carry out the proposed sarcoma research.

Due Date: Letter of Intent Due: November 6, 2026 at 10:59pm CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The Collaborative Catalyst Research Award is intended to support a multi-institutional project for a total of up to $900,000. Each sub-project can be awarded up to $300,000, with PIs representing at least two different institutions.

Max Amount and Period: $900,000 over 2 years

Eligibility: Research team must consist of a contact PI and up to two collaborating Pis. Teams must be multi-institutional. See RFA for more details.

Due Date: November 9, 2026 at 10:59pm CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The ASH Treating Fairly Research Award program was established in response to concerns about recent shifts in federal funding priorities, which have reduced support for research focused on hematologic diseases and disorders that disproportionately affect specific communities. ASH has long recognized the importance of addressing this and remains committed to advancing fair outcomes for all patients. Securing funding for research that supports this mission is essential.

Max Amount and Period: $200,000 over 1-3 years

Eligibility: Applicants must be MD/DO, or MD/DO-PhD, or PhD, or PharmD. Applicants must have completed their residency or terminal doctoral degree (if PhD or PharmD) more than 13 years prior to the application deadline. Applicants must hold a faculty appointment and have $500,000 or less in other resources available excluding institutional funding, salary/fringe, and donated clinical trial supplies.

Due Date: November 15, 2026

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The CRI Technology Impact Award is designed to support early-stage, pre-development concepts — innovations that have not yet been built or tested, but that hold the potential to transform the landscape of cancer immunotherapy. Technology Impact Awards are not intended to fund the continuation or refinement of existing technologies. Instead, they support visionary, high-risk/high-reward ideas that could lay the groundwork for a new generation of tools, platforms, and systems capable of overcoming the most critical barriers in the field.

Max Amount and Period: $600,000 over 2-4 years

Eligibility: Applicants must hold a tenure-track position at a not for profit research center or institution. Clinical cancer immunologists and technology developers are encouraged to collaborate. Co-PIs are eligible and encouraged to apply.

Due Date: Letter of Intent Due: November 16, 2026

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: Clinical trials must be interventional, early to late stage (Phase 1, 2, and 3); they may include secondary non-clinical endpoints. Applications must have patient partner involvement.

Max Amount and Period: $500,000 over 5 years

Eligibility: Applicants must hold a doctoral degree and have a faculty appointment (or equivalent) with an academic institution, including research institutions that are not formally associated with a university, at the time of the award term. Both early-career and established investigators are encouraged to apply. An applicant must be an independent investigator with demonstrated experience and training to be able to organize, manage, and implement the clinical trial to meet milestones and timelines, and to protect the rights and welfare of the human subject participant. The application must convey the institution’s commitment to both the applicant and the proposed research activities. RTFCCR does not have any geographical or cancer type restrictions. International teams are welcome.

Due Date: Letter of Intent Due: November 23, 2026

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: Mission Boost Grants (MBG) are designed to support research projects that specifically focus on translation to human testing. MBGs are opportunities for independent investigators at all levels to apply for additional, or “boost,” resources for innovative, clinical-enabling projects. Stage I requires the investigator to develop outcome-specific, unequivocal milestones that reduce the risks of studying a new drug, device, or procedure in patients.

Max Amount and Period: $270,000 over 2 years

Eligibility: Applicants must work at an academic institution or nonprofit in the US and be an independent investigator with a full-time faculty appointment. Applicants may be at any career stage.

Due Date: December 1, 2026

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: Mission Boost Grants (MBG) are designed to support research projects that specifically focus on translation to human testing. MBGs are opportunities for independent investigators at all levels to apply for additional, or “boost,” resources for innovative, clinical-enabling projects. Stage II supports testing in cancer patients.

Max Amount and Period: $545,000 over 18 months

Eligibility: Applicants must have previously held or currently hold a Stage 1 Mission Boost Grant for a minimum of 18 months AND have completed Stage 1 milestones. They must work at an academic institution or nonprofit in the US and be an independent investigator with a full-time faculty appointment. Applicants may be at any career stage.

Due Date: December 1, 2026

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The ACS Research Scholar Grants provide support for independent, self-directed researchers. Grant proposals are investigator-initiated and may pursue questions across the cancer research continuum, as long as they fit within an American Cancer Society (ACS) priority research area.

Max Amount and Period: $860,000 over 4 years

Eligibility: Applicants must work at an academic institution or nonprofit in the US and be an independent investigator with a full-time faculty appointment. They must not have been the PI on more than 1 R01 or R01-equivalent grant at the time of application (meaning a grant that is more than $100,000 in direct costs per year for more than 3 years). For new RSG applications, applicants must have had their first appointment as an independent, full-time faculty members less than or equal to 8 years ago. Resubmissions from investigators beyond the 8-year cutoff require prior approval from ACS.

Due Date: December 1, 2026

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The Clinician Scientist Development Grant (CSDG) supports full-time faculty members in becoming independent investigators as clinician scientists. This grant is designed for people trained primarily as clinicians who want to maintain clinical practice and conduct cancer research.

Max Amount and Period: $405,000 to $675,000 over 3-5 years

Eligibility: Applicants must work at an academic institution or nonprofit in the US, have a doctoral degree, an active clinical license, and participate in clinical care. They must not currently or have been a PI of an individual mentored training grant. They must also not have been the PI of an independent extramural research grant that is more than 1 year AND more than $100k direct costs, including multi-PI awards.

Due Date: December 1, 2026

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The American Cancer Society (ACS) and the American Society for Radiation Oncology (ASTRO) have partnered to co-fund one Clinician Scientist Development Grant (CSDG). The goal of the ASTRO-ACS CSDG is to foster the research career of a clinician scientist in radiation oncology. This grant is designed for people trained primarily as clinicians who want to maintain clinical practice and conduct cancer research. The investigator selected for funding will be required to become a member of ASTRO prior to grant activation.

Max Amount and Period: $405,000 to $675,000 over 3-5 years

Eligibility: Applicants must work at an academic institution or nonprofit in the US, have a doctoral degree, an active clinical license, and participate in clinical care in the radiation oncology field. Board-certified clinical medical physicists may also apply. They must not currently or have been a PI of an individual mentored training grant. They must also not have been the PI of an independent extramural research grant that is more than 1 year AND more than $100k direct costs, including multi-PI awards.

Due Date: December 1, 2026

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The CRI Clinical Innovator supports pioneering immunotherapy clinical trials designed and led by academic researchers. These investigator-initiated studies are vital to improving patient outcomes, addressing areas of high unmet need, and generating critical mechanistic insights that can guide the future of cancer treatment.

Max Amount and Period: $1M per trial

Eligibility: Candidates must be the Principal Investigator (PI) of the proposed study. CRI has no citizenship restrictions, and research supported by the award may be conducted at medical schools or research centers in the United States or abroad. Please note that CRI does not support research at for-profit institutions.

Due Date: Letter of Intent Due: December 1, 2026

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The CRI Clinic and Laboratory Integration Program (CLIP) supports innovative investigations at the intersection of laboratory discovery and clinical application in cancer immunology.

Max Amount and Period: $300,000 over 2 years

Eligibility: Candidates for a CRI CLIP Grant must hold a faculty appointment as a tenure-track assistant professor (or higher rank) at the time of award activation. If not, documentation from their institution must accompany the Letter of Intent indicating they will hold the position of assistant professor (or higher rank) by the time of award activation. CRI has no citizenship restrictions, and research supported by the award may be conducted at medical schools and research centers in the United States or abroad. Please note that CRI CLIP Grants do not support research at for-profit institutions.

Due Date: Letter of Intent Due: December 1, 2026

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This award was created to help stimulate and inform important public policy debates around healthy air, climate change and other public health issues related to the lungs and lung health. This award supports research on and evaluation of existing public policy and public health programs, as well as projects that inject innovative ideas into public policies impacting lung health. Areas of interest include, but are not limited to: tobacco control, air quality, lung health policy, differences in health outcomes, access to care, modeling, and/or informatics.

Max Amount and Period: $100,000 over 2 years

Eligibility: Applicants must possess a doctoral degree and hold a full- time faculty position at an academic institution (or its equivalent in research institutions not formally affiliated with a university).

Due Date: December 1, 2026 at 10:59pm CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: AAI’s RESTORE Grant Program provides up to one year of funding for AAI member-led research projects funded by grants that were unexpectedly frozen or terminated by NIH or other federal government agencies for reasons other than scientific merit.

Max Amount and Period: $100,000 per award

Eligibility: The applicant must be the Principal Investigator (PI) or co-PI of an immunology-focused NIH R-, K-, or F-series grant (including K99/R00 and F99/K00 grants), or DP2 or DP5 grant, or a grant from NSF or another U.S. federal agency, that was awarded to an eligible institution (see below) AND was terminated in 2025 or 2026 due to non-scientific reasons. Be an AAI member in good standing for at least two of the last three years (2024-2026) and at the time of application.

Due Date: ROLLING DEADLINE until December 1, 2026

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The Elsa U. Pardee Foundation funds research to investigators in United States non-profit institutions proposing research directed toward identifying new treatments or cures for cancer. The Foundation funds projects for a one-year period which will allow the establishment of capabilities of new cancer researchers or new cancer approaches by established cancer researchers. It is anticipated that this early-stage funding by the Foundation may lead to subsequent and expanded support using government agency funding. Project relevance to cancer detection, treatment, or cure should be clearly identified.

Max Amount and Period: No limit for 1 year

Eligibility: Priority is given to researchers at non-profit institutions in the United States who are new to the field of cancer research, or to established research investigators examining new approaches to cancer cure.
Post-docs are eligible to apply and need to have an independent researcher included as a co-PI.

Due Date: December 1, 2026

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The objective of the AGA Research Foundation Research Scholar Award (RSA) is to support early-career investigators working toward independent and productive research careers in digestive diseases by ensuring that a major proportion of their time is protected for mentored research.

Max Amount and Period: $300,000 over 3 years

Eligibility: Applicants for this award must hold an MD, PhD and/or equivalent degree (e.g., MBChB, MBBS, DO), and a full-time faculty or equivalent position at an institution in North America (U.S., Canada or Mexico) by the start date (i.e., July 2027) of this award. See RFA for full eligibility details.

Due Date: December 2, 2026

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The objective of this AGA Research Foundation Research Scholar Award (RSA) is to support early-career investigators working toward independent and productive careers in pancreatic cancer research by ensuring that a major proportion of their time is protected for mentored research (i.e., a minimum of 50 percent effort dedicated to the proposed project). The award will support junior faculty (not fellows) who have demonstrated exceptional promise and have some record of accomplishment in research.

Max Amount and Period: $300,000 over 3 years

Eligibility: Applicants must be MD, PhD, and/or equivalent and be a full-time faculty member. Applicants must classify as “early career” according to specific criteria. See RFA. For MDs, no more than 7 years since completion of clinical training and the award start date. For PhDs, no more than 7 years since conferment of the PhD degree and the award start date.

Due Date: December 2, 2026

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The Pancreatic Cancer Action Network Career Development Award represents an effort to encourage and support junior faculty to conduct pancreatic cancer research and establish successful career paths in this field. The grants provide $250,000 over two years for junior investigators that have yet to secure their first major research funding. The research proposed for funding may be basic, translational, clinical or epidemiological in nature and must have direct applicability and relevance to pancreatic cancer. Special consideration will be given to understudied areas in pancreatic cancer research.

Max Amount and Period: $250,000 over 2 years

Eligibility: Applicants must have a doctoral degree (including PhD, MD, DO, DC, ND, DDS, DVM, ScD, DNS, PharmD or equivalent) in the biomedical sciences and hold a faculty position of Instructor, Research Assistant Professor, Assistant Professor or the equivalent. Applicants must have completed their most recent doctoral degree within the past 11 years. Applicants must not have currently or previously served as a principal investigator on major research awards or grants (e.g., NIH R00, NIH R01 or equivalent).

Due Date: December 9, 2026

Application Assistance: Washington University faculty may reach out to Batool Akhtar-Zaidi in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The Young Investigator grant is a three-year award designed to support early career researchers, such as postdoctoral fellows, clinical fellows or instructors, pursuing promising childhood cancer research ideas. These grants aim to cultivate the best and brightest researchers of the future who demonstrate a commitment to a research career in pediatric cancer. A mentor is required, and a career development plan must be included.

Max Amount and Period: $180,000 over 3 years

Eligibility: Applicants must have an MD, PhD, or MD/PhD or equivalent and must not have achieved an appointment higher than Instructor. Assistant Professors, including adjuncts at this level, will not be considered. Applicants not from accredited clinical fellowship programs must meet specific criteria. See full RFA. A minimum of 75% of the applicant’s time during the Young Investigator period must be allocated as non-clinical protected time for all research activities. This percentage of time includes both Young Investigator activities and the applicant’s other research responsibilities. Research mentor(s) must be identified and have a track record in pediatric cancer research.

Due Date: December 10, 2026 at 7pm CST

Application Assistance: Washington University faculty may reach out to Batool Akhtar-Zaidi in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: To promote the establishment of a new generation of basic and translational scientists interested in tackling inherited hematologic malignancy predisposition disorders with a focus on RUNX1-familial platelet disorder. We believe that providing capital to early career investigators not only injects funding to where it is needed most, but also cultivates a new cohort of investigators who will be invested in an area of research that historically has had limited attention.

Max Amount and Period: $180,000 over 3 years

Eligibility: Applicant institutions may be based in the U.S. or outside of the U.S. Applicants need not be United States citizens. Funds must be granted to non-profit institutions or organizations. Applicants must have an MD, PhD, or MD/PhD (DO, MBBS, or equivalent) and be within five years of their first faculty appointment as an Assistant Professor or equivalent tenure-track position. Associate and Full Professors are ineligible. If at the Instructor level, the applicant must submit a letter of support from their mentor at the sponsoring institution. A minimum of 75% of the applicant’s time during the award period must be allocated as protected time for all research activities. This percentage of time includes both activities on this grant and the applicant’s other research responsibilities. Applicants may have research grants from other funding sources during the award period, but there must be clear documentation of mechanisms to avoid scientific and budgetary overlap. Applicants must have research experience working in, and a deep understanding of, normal or malignant hematopoiesis and/or immunology.

Due Date: December 17, 2026 at 7pm CST

Application Assistance: Washington University faculty may reach out to Batool Akhtar-Zaidi in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The ASH Clinical Research Training Institute (CRTI) is a unique, year-long education and mentoring program for hematology fellows and junior faculty at academic medical centers. CRTI offers a broad education on clinical research methods, research collaborations, statistical analysis, and managing the demands of family and career. The goal of the program is to produce leaders armed with ideas for clinical hematology research and the tools and resources to make their ideas a reality.

Max Amount and Period: ASH will cover participants’ travel and hotel expenses to attend summer workshop and spring meeting.

Eligibility: This opportunity is geared towards early-career faculty in hematology-related programs at academic medical centers. See RFA for full details.

Due Date: Letter of Intent Due: December 17, 2026 at 10:59pm CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The CRI Lloyd J. Old STAR Program — Scientists TAking Risks — provides long-term, flexible funding to mid-career scientists, giving them the freedom to pursue high-risk, high-reward research at the leading edge of cancer immunotherapy. Rooted in CRI’s unparalleled track record of identifying and supporting individuals who have reshaped the field, these awards are not tied to a single research project. Instead, they are designed to support outstanding investigators whose body of work demonstrates exceptional promise and the potential for transformative impact.

Max Amount and Period: $1.25M over 5 year period

Eligibility: The applicant must have an MD, PhD, or MD/PhD and hold a tenure-track posiion. Assistant professors with a minimum of 3 years in that role and associate professors with a maximum 3 years may apply.

Due Date: January 15, 2027

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.